CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
Conditions:
Mitral Regurgitation
Sponsor: Universitätsklinikum Hamburg-Eppendorf
trial.available_in:
БГ
Overview
This multinational, investigator-initiated, retrospective study aims to investigate outcomes of patients, who underwent transcatheter mitral valve implantation (TMVI), in comparison to those screened for TMVI but deemed ineligible, who subsequently underwent interventional mitral valve edge-to-edge repair, mitral valve surgery or medical/conservative therapy.
Who can participate
Inclusion Criteria:
* clinically significant mitral insufficiency
* patient underwent screening for TMVI
* echocardiography data at baseline (and after TMVI, E2E and surgery)
* follow-up of at least 30 days
Exclusion Criteria:
\- age under 18 years
БГ